Background Women with BRCA1 and BRCA2 mutation carriers are at substantially elevated
risk of developing ovarian cancer. The aim of the meta-analysis is to clarify the role of risk …

STUDY QUESTION Does surgical treatment of endometriomas impact on the ovarian
reserve as evaluated with antral follicle count (AFC)? SUMMARY ANSWER This meta …

Ovarian cancer is the most common cause of gynecological cancer-related mortality, with
the majority of women presenting with advanced disease; although chemotherapeutic …

Background Carboplatin plus paclitaxel administered every 3 weeks is standard first-line
chemotherapy for patients with advanced ovarian cancer. A weekly paclitaxel schedule …

Objective To evaluate the excised specimen with histologic analysis and to assess the antral
follicle count (AFC) at follow-up. This is to determine whether excisional surgery for recurrent …

The high recurrence rate and the low overall survival in ovarian cancer suggest that a more
specific therapeutic approach in addition to conventional treatment is required. Translational …

Ovarian cancer (OC) remains a fatal malignancy because most patients experience
recurrent disease, which is resistant to chemotherapy. The outcomes for patients with …

Ovarian endometriomas affect 17 to 44% of women with endometriosis, and are often
associated with pelvic pain and infertility. Treatment options include expectant management …

Objective The purpose of this study was to explore in greater depth the outcomes of the
Italian randomized trial investigating the role of pelvic lymphadenectomy in clinical early …

Background Women with BRCA1 and BRCA2 mutations have substantially elevated risk of
developing breast cancer. The aim of this study was to clarify the role of bilateral risk …